Description
SYRINGE-TRIVALENT
First action · last action
2015-06-05 · 2015-06-05
Transactions
1
First transaction's obligation
$156,000
Base + all options value (sum of deltas)
$156,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
Parent IDV
VA797P15C0037
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-06-05+$156,000= $156,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-06-05 | +$156,000 | $156,000 | SYRINGE-TRIVALENT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SXN5GSFJKUU4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA69D16F0279 | 69D-NETWORK CONTRACT OFFICE 12 · 6505 · DRUGS AND BIOLOGICALS | $46,800 | FY2016 |
| VA24515F0750 | 688-WASHINGTON DC · 6505 · DRUGS AND BIOLOGICALS | $98,800 | FY2015 |
| VA26115F2381 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $2,756 | FY2015 |
| VA26115F2377 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $4,784 | FY2015 |
| VA26115F2376 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $52,000 | FY2015 |
| VA26115F2382 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $2,756 | FY2015 |
Other recipients under 6810 from 260-NETWORK CONTRACT OFFICE 20 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26016F0238 | APO-PHARMA USA, INC. | 260-NETWORK CONTRACT OFFICE 20 | $5,049 | FY2016 |
| VA26016P0153 | MCKESSON CORPORATION | 260-NETWORK CONTRACT OFFICE 20 | $3,500 | FY2016 |
| VA26016P0162 | MCKESSON CORPORATION | 260-NETWORK CONTRACT OFFICE 20 | $4,686 | FY2016 |
| VA26016F0010 | APO-PHARMA USA, INC. | 260-NETWORK CONTRACT OFFICE 20 | $5,048 | FY2016 |
| VA26016F4147 | JAZZ PHARMACEUTICALS, INC | 260-NETWORK CONTRACT OFFICE 20 | $0 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26015F3131_3600_VA797P15C0037_3600 · retrieved 2026-09-26.